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Summary Transforming growth factors have a wide range of biological activities related to cell proliferation
and differentiation. In general TGF-a promotes cell proliferation while TGF-P may stimulate or inhibit
proliferation depending on the cell type and growth factor environment. Cultured human keratinocytes, skin
and oral squamous cell carcinomas were analysed for the presence of transcripts and protein for the
transforming growth factors a & P. Both growth factors were detected in cultured keratinocytes (which have
receptors for and respond to both ligands), and in medium conditioned by these cells. Additionally transcripts
for TGF-a were found preferentially in the basal, proliferative compartment of cultured keratinocytes.
Similarly both growth factors were detected in oral squamous cell carcinomas and a highly significant inverse
correlation was found between the levels of TGF-a and the epidermal growth factor receptor in these tumours.
The data for TGF-a are consistent with the existence of an autocrine growth control loop influencing cell
proliferation in both a normal cell type and malignant epithelial tissues, a process that in keratinocytes and
responsive squamous cell carcinomas could be modulated by TGF-,B.
Transforming growth factors were originally identified and
defined by their ability to induce reversible transformation of
selected normal mammalian cells in culture. Exposure of
anchorage-dependent cells to transforming growth factors
can stimulate growth and allow cells to grow anchorage-
independently and form colonies in soft agar (De Larco &
Todaro, 1978; Roberts et al., 1981). The identification of
such factors led to the proposal of an autocrine mechanism
of growth control, with transformed cells able to respond to
self-produced growth factors (Sporn & Todaro, 1980; Sporn
& Roberts, 1985).
Two distinct forms of transforming growth factors are now
recognised, transforming growth factor alpha (TGF-a) and
transforming growth factor beta (TGF-13). TGF-a is a single
chain polypeptide, related to epidermal growth factor (EGF)
(Marquaradt et al., 1984; Derynck et al., 1984), able to
stimulate growth by binding to and activating the epidermal
growth factor receptor (EGFR) (Todaro et al., 1980; Mas-
sague, 1983a). TGF-a was originally described in the culture
medium of retrovirally transformed fibroblasts (De Larco &
Todaro, 1978; Ozanne et al., 1980: Roberts et al., 1980), and
was subsequently detected in a number of squamous cell
carcinoma (SCC) lines (Derynck et al., 1987). This molecule
has also been shown to be produced by a variety of normal
sources including cells of the bovine anterior pituitary gland
(Samsoondar et al., 1986), cultured human keratinocytes,
skin (Coffey et al., 1987) and the maternal decidua during
embryonic development (Han et al., 1987). The physiological
effects of TGF-a are unclear, but it can prolong the lifespan
of cultured keratinocytes by stimulating lateral migration of
dividing keratinocytes in expanding colonies (Barrandon &
Green, 1987), suggesting a role in epidermal homeostasis.
TGF-,B, a two chain polypeptide, is a member of a complex
family of structurally related growth and differentiation fac-
tors. Several related forms of TGF-P have been described,
including: TGF-p1, originally purified from human platelets
(Derynck et al., 1985) but now known to be widespread in
tissues; TGF-P2, isolated from bovine bone (Seyedin et al.,
1987), porcine platelets (Cheifetz et al., 1987) and a human
glioblastoma cell line (de-Martin et al., 1987); TGF-,13.2, a
heterodimer of P1 and 12 subunits isolated from porcine
platelets (Cheifetz et al., 1987); and TGF-P3, recently isolated
from a human rhabdomyosarcoma cell line (Duke et al.,
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1988). The various forms of TGF-P bind to a set of three
structurally and functionally distinct cell surface receptors
(Cheifetz et al., 1987).
TGF-P can be present in transformed cells which produce
TGF-<x (Anzano et al., 1983; Massague, 1983b) and has also
been identified in a wide range of human malignant cell lines
and in normal cells of the haemopoietic and immune systems,
liver and lung (Derynck et al., 1987). It appears that most, if
not all, cells secrete TGF-P predominantly in a latent form
which, in vitro, after exposure to extremes of pH or pro-
teolytic activation binds to its receptor (Lawrence et al.,
1985; Lyons et al., 1988). The physiological mechanisms of
TGF-P activation remain unclear.
Although TGF-,B stimulates proliferation of some fibrob-
last cell types in culture (Tucker et al., 1983), it has a growth
inhibitory effect on epithelial cells both in vitro and in vivo,
including bronchial epithelium (Holley et al., 1983; Masui et
al., 1986; Jetten et al., 1986) and mammary cells (Holley et
al., 1983; Knabbe et al., 1987; Silberstein & Daniel, 1987),
keratinocytes (Shipley et al., 1986; Ozanne et al., 1986; Reiss
& Sartorelli, 1987), and hepatocytes (Hayashi & Carr, 1985).
In contrast a number of SCC lines fail to respond to the
inhibitory effects of TGF-P (Ozanne et al., 1986; Shipley et
al., 1986). The same authors postulated that TGF-P may play
a role in the regulation of normal epithelial growth, via a
negative regulatory mechanism with lack of response to
TGF-P leading to altered growth in carcinomas.
We have examined a series of oral SCC, cultured kera-
tinocytes and normal skin for evidence of the production of
TGF-a and P using protein and Northern blot analysis. In
some cases we also examined EGF and EGFR expression.
The investigation was designed to determine whether these
growth factors were produced in situ and therefore could
potentially play an autocrine role in the regulation of normal
and malignant cell proliferation.
Materials and methods
Cell culture
Human keratinocytes derived from newborn foreskin (pas-
sage numbers 3- 11) were grown in the presence of a mito-
mycin C treated 3T3 feeder layer (strain J2), in three parts
Dulbecco's modified Eagle's medium (DMEM) and one part
Ham's F12 supplemented with 1.8 x 10-4M adenine, 10% fetal
calf serum (FCS), 5 jigml-' insulin, 0.4jigml-' hydrocor-
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tisone, 8.4 ng ml-' cholera toxin and 10 ng ml-' EGF (Allen-
Hoffman & Rheinwald, 1984). The medium was changed
every 2 days. EGF was omitted from the culture medium in
some experiments. Before the keratinocytes were harvested
for cell separation experiments, RNA purification or, before
collection of conditioned media, any remaining 3T3 cells
were removed by vigorous washing with isotonic EDTA (Sun
& Green, 1976). Human foreskin fibroblasts Detroit 532
(ATCC CRL 54) a bronchial epithelial carcinoma cell line
A549 (ATCC CRL 185) and a vulval carcinoma cell line
A431 (ATCC CRL 1555) were maintained in DMEM with
10% FCS. A human bladder carcinoma cell line, T-24
(ATCC-HT B-4), and human fetal fibroblasts were grown in
RPMI and 10% FCS.
Cell separation experiments
Density gradient centrifugation of cultured keratinocytes was
performed essentially as described by Fischer et al. (1982).
Keratinocytes were filtered through a fine mesh nylon memb-
rane to minimise clumping and aliquots of 3 x 107 cells
suspended in 50% stock Percoll solution in phosphate
buffered saline (PBS) (Pharmacia Fine Chemicals, Uppsala,
Sweden). The suspension was centrifuged in a Sorval vertical
SS 34 rotor at 16,000 r.p.m. (20,000g) for 30 min at 4'C.
After centrifugation two bands of concentrated cells were
apparent. The upper band (density 1.049) was enriched for
the larger, less dense, spinous, granular or squamous cells,
the lower band (density 1.098) for the smaller spherical cells
with a high nuclear-to-cytoplasmic ratio characteristic of ba-
sal cells. Keratinocytes were harvested through a thin-walled
capillary tube with the aid of a peristaltic pump and washed
in PBS. The reproducibility of these self-generating gradients
was monitored by the use of percoll density marker beads.
Keratinocytes were also separated on the basis of size by
passage through a Nitex nylon monofilament screen (type
HC-3-1 I Tetko: Watt & Green, 1982). Cells derived from the
basal layer generally passed through the membrane while the
larger subrabasal cells were excluded.
Preparation of cell, tissue extracts and conditioned mediumJor
TGF-a protein determination
Cell and tissue extracts were prepared by a modification of
the acid/ethanol procedure (Roberts et al., 1980). Frozen
tissues (0.2-0.8 g) or cultured keratinocytes (4- 12 x 107
cells) were suspended (3 ml g-' of tissue; 1 ml per 107 cells) in
a solution of absolute ethanol containing 0.2 M HCl, 30tLM
phenylmethylsulphonylfluoride (PMSF) and 5 g ml-' peps-
tatin. The volume was increased one-third with distilled
water and samples homogenised in a polytron (model PTA
10-35) for 30-60 s at 4'C before further PMSF was added.
After overnight extraction at 4'C samples were centrifuged
and re-extracted with the aqueous acid/ethanol solution.
To prepare conditioned medium (CM), near confluent
dishes of keratinocytes were washed in serum-free media
(SFM: DMEM and 25 mM Hepes buffer) and then washed
three times at 2 h intervals. Finally cells were incubated for
24 h in SFM and CM collected. CM was dialysed against
repeated changes of PBS using Spectra/por dialysis memb-
rane, 3,500 molecular weight cut off, until the phenyl red
colour was absent or greatly diminished.
Aliquots of CM (50 ml) or pooled acid/ethanol tissue ext-
racts were trace enriched for growth factors using disposable
C18 'sep-pak' reverse phase columns (Waters). Columns were
prepared by washing sequentially with 3 ml of methyl alco-
hol, 3 ml of isopropanol and 5 ml of distilled water. Tissue or
cell extracts were diluted 6-7-fold to reduce the ethanol
concentration to approximately 10% and immediately loaded
onto the column. The column was washed with 5 ml of PBS
and bound material eluted using 50% (v/v) acetonitrile,
20 mM sodium phosphate buffer, pH 7.5. The first 500 gsl of
eluate was discarded, TGF-a and other bound material being
eluted in the next 800 gLI. Progress was conveniently followed
by monitoring the elution of phenyl red added to the ext-
racts. Acetonitrile was evaporated under a gentle stream of
nitrogen and samples frozen at - 20'C unless assayed imme-
diately. The recovery of a 5 nM TGF-a solution from the
'sep-pak' column was shown to be 80-90%. TGF-a radioim-
munoassay was conducted using a commercially available kit
(Biotope Inc., Seattle).
Preparation ofcell, tissue extracts and conditioned mediumfor
TGF-P radioreceptor assay
Cell and tissue extracts were prepared using the acid/ethanol
procedure essentially as described for TGF-x. After overnight
extraction at 4°C, extracts were clarified by centrifugation in a
microfuge and were dialysed against repeated changes of 1 M
acetic acid and concentrated by lyophilisation. Samples were
reconstituted in binding buffer for the radioreceptor assay
(DMEM, 0.1% BSA and 25 mM Hepes buffer). Conditioned
medium was prepared by washing cells in SFM as described
above and after addition of 2 mM PMSF and 0.1% BSA was
clarified by centrifugation at 100,000 g for 30 m. Acidified
CM for determination of the total amount of TGF-13 present
(precursor and active forms) was prepared by dialysis against
repeated changes of 1 M acetic acid and concentrated by
lyophilisation. Neutral aliquots of CM for determination of
active TGF-,B was prepared by dialysis against PBS followed
by 20 mM ammonium bicarbonate prior to lyophilisation.
TGF-P radioreceptor assay
The 125I TGF-P radioreceptor assay was performed by a
modification of the method described by Frolick et al. (1984).
Cell and tissue extracts were assayed for TGF-P like activity
by testing the ability of various concentrations of extract or
CM to inhibit the binding of '25I TGF-P, (50,000 c.p.m. per
well, R & D Systems Inc., Minneapolis) to A549 cells plated
in 24-well cluster plates (2 x I05 cells per well) at 4'C using
the sequential assay protocol described by Assonian et al.
(1987). Bound counts were normalised as a percentage of
counts bound in control wells (typically>8000c.p.m.) less
than non-specific binding (typically <2000 c.p.m.) in the pre-
sence of an excess (10 nM) of unlabelled TGF-P. The concent-
ration of TGF-,B was calculated by reference to a standard
competition curve. The radioreceptor assay does not distin-
guish between TGF-p1, 2, 1.2 or 3.
Neutral samples of CM were assayed in a similar fashion
and in some experiments 200 1I samples were preincubated
overnight at 4'C with 50,lg of neutralising antibody to TGF-
P (R & D Systems Inc.). This antibody neutralises 90% of
the inhibitory effect of I ng ml- recombinant TGF-P on
thymidine incorporation into mink lung epithelial cells.
Immunohistology
EGFR expression was investigated by means of an alkaline
phosphatase (APAAP) technique using a monoclonal anti-
body which recognises the external domain of the EGFR
designated EGFR1 (Waterfield et al., 1982). The level of
receptor expression was formulated into an EGFRI stain
index based on a score for both the stain intensity with the
antibody and the proportion of tumour in the specimen
(Partridge et al., 1988). The histological type of the tumour
was assigned a score value: well differentiated = 1, well/mod-
erate = 2, moderate = 3, moderate/poor = 4, poorly differ-
entiated = 5.
RNA purification and hybridisation
RNA was isolated from frozen tumours (2-5 g) or human
skin (5-25 g) by homogenisation under liquid nitrogen, lysis
in guanidine thiocyanate (GT) and subsequent extraction
with lithium chloride/urea (Auffray & Rougeon, 1980). After
removal of the feeder layer, keratinocytes were lysed in GT
and RNA sedimented through caesium chloride (Maniatis,
1982). RNA was extracted from cell lines using the same
technique. The polyadenylated RNA fraction was isolated by544 M. PARTRIDGE et al.
one cycle of oligo-dT cellulose chromatography (Aviv &
Leder, 1972). RNA was electrophoresed on a 1% agarose/
formaldehyde gel and transferred to a nitrocellulose filter.
Human cDNA inserts comprising the complete coding
sequence for TGF-.a (Derynck et al., 1984), TGF-P1 (1,050
base pairs; Derynck et al., 1985), TGF-P2 (1,695 base pairs;
de Martin et al., 1987) or pre-pro EGF (1,860 base pairs;
Scott et al., 1985) were labelled by oligonucleotide priming
(1-2 x 106 c.p.m. ml-'). Hybridisation was performed for
16 h at 42°C in 50% formamide, 5 x SSC, 1 x Denhardts,
0.05 M phosphate buffer pH 6.6, 500 fg ml-' salmon sperm
DNA and 0.2% SDS. Filters were washed twice at room
temperature in 2 x SSC, 0.5% SDS and twice at 50°C in
0.2% SSC, 0.5% SDS. As a control for the cell separation
experiments filters were re-hybridised with an a-actin cDNA
insert (Gunning et al., 1983) to assess the amount of RNA in
each track.
An oligonucleotide probe to human EGF, with less than
60% homology to any area of the known TGF-a sequence
(12 nucleotides from 3383-3403; see Bell et al. (1986) was
end labelled using T4 polynucleotide kinase and 32P-yATP
and hybridised with the filter for 16 h at 42°C in 5 x Den-
hardts, 1% ficoll, 1% polyvinylpyrolidone, 1% BSA, 1O mM
EDTA pH 7.5, 0.5% SDS. Filters were washed four times at
25°C in 2 x SSC and in 0.2% SSC, 0.1% SDS for 12 min at
42°C (Berent et al., 1985).
Tissues
Samples of normal skin and oral SCC for use in growth
factor studies were obtained from surgical biopsies and tu-
mour resections. These tissues were frozen in liquid nitrogen
immediately after surgical excision.
vested from these cells (Table I). Pretreatment of keratino-
cytes with EGF markedly increased the rate of secretion of
TGF-a as previously reported (Coffey et al., 1987). Analysis
of skin showed low levels of protein in both neonatal fore-
skin (1.5 ng per g wet wt) and adult (0.16-0.35 ng per g wet
wt) samples.
TGF-P1 transcripts (2.5 kb) were detected in cultured
keratinocytes and also in fibroblast cell lines (Figure 3).
Stimulation of keratinocytes with EGF increased the level of
TGF-P1 transcripts. Rehybridisation of the filter shown in
Figure 2 with the TGF-P1 probe showed that transcripts were
again found predominantly in the basal cell compartment of
cultured keratinocytes although transcripts were also detect-
able in the differentiating cells (not shown). This observation
was confirmed by analysis of RNA obtained following separa-
tion of cells by size fractionation (Figure 4). TGF-PI tran-
scripts were also detected in human skin (Figure 4), while
TGF-P2 transcripts were not detected in cultured keratinocytes
or skin (not shown). Low levels of total TGF-P protein
(precursor and active forms) were detected in acidified cell
extracts of cultured keratinocytes (2.4 ng per 107 cells) and in
CM obtained from these cells (16 ng per 107 cells per 24h.
Table II). An increased amount of TGF-P in both cells and
CM was observed following pre-treatment with EGF. Assay of
neutral keratinocyte CM revealed that less than 5% ofTGF-P
was secreted in the active conformation. Pre-incubation of
samples of neutral CM with the neutralising antibody to TGF-
P abolished>70% of its activity further confirming the
specificity of the radioreceptor assay. TGF-P protein was also
detected in acidified cell extracts of normal epidermis (I ng per
g wet wt) and dermis (4-6 ng per g wet wt). Neutral cell or
tissue extracts were not assayed for active TGF-P.
Production of TGF-a and P by oral squamous cell carcinomas
Results
Production of TGF-a and by cultured keratinocytes and skin
TGF-x transcripts (4.5 kb) were detected in normal cultured
keratinocytes (Figure 1). In some experiments a small tran-
script (2.3 kb) was also seen. Cell density separation experi-
ments indicated that TGF-a transcripts were predominantly
found in keratinocytes having the basal phenotype in vitro
(Figure 2). These transcripts could not be detected in normal
adult skin. TGF-a protein was detected both in low (p3) and
high (p9) passage cultured keratinocytes and in CM har-
Oral SCC Keratinocytes A431
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Figure 1 Northern hybridisation for TGF-a mRNA using
polyadenylated (A +) RNA (10 jAg) and total (T) RNA (40 jLg)
from oral squamouse cell carcinoma (SCC), cultured
keratinocytes and A431 cells.
TGF-a transcripts (examples in Figure 1) and protein
(0.5-9.0 ng per g wet wt; Table 111) were seen in all oral SCC
examined. While we cannot exclude the possibility that a
proportion of the TGF-a detected arises from the tumour
stroma, this seems unlikely as TGF-a production is not
usually associated with mesenchyme. The specific presence of
TGF-a in the epithelial component of some tumour samples
was further confirmed by immunocytochemistry (S. Cartil-
idge, personal communication; not shown). TGF-pI trans-
cripts (examples in Figures 3 and 4) and protein (2-6 ng g-'
of tissue) were also found in all six oral SCC examined.
These levels were equivalent to that seen in normal samples
of epidermis and dermis (Table II).
Keratinocytes
Adult skin basal differentiating J2 T-24
A+ T A+ T A+ T A+ T A+ A+
4.5 kb
Figure 2 Northern hybridisation for TGF-a mRNA using
polyadenylated (A+) RNA (10 fig) and total (T) RNA (40 gg)
from skin tissue, percoll density separated cultured keratinocytes,
J2 (3T3), and T24 cells.
Table I TGF-a detected in human keratinocytes and conditioned media
Cultured human keratinocytes Conditioned media
Without With Without With
EGF EGF EGF EGF
p9 0.32 ng per 107 cells 0.32 ng
p3<0.1 ng <0.1 ng
1.1 ng per I07 cells per 24 h 3.7 ng
0.74ng 3.8ng
Keratinocyte extracts and conditioned media were prepared as described in
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Keratinocytes
+EGF -EGF
I I I I
A+ T A+ T
Detroit 532 Fetal fibroblasts
A+ T A+ T A
Figure 3 Northern hybridisation for TGF-P mRNA using polyadenylated (A+) RNA (10 psg) and total (T) RNA (40 rig) from
cultured keratinocytes, Detroit 532 cells, fetal fibroblasts and oral squamous cell carcinoma tissue.
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Figure 4 Northern hybridisation for TGF-P mRNA using polyadenylated (A+) and total (T) RNA (fg as indicated) from
cultured keratinocytes, skin and oral squamous cell carcinomas.
Immunohistology
Table 11 TGF-P detected in keratinocyte cell extracts, conditioned
media, human epidermis and oral squamous cell carcinomas
Total Active
TGF-pa TGF-Pb
Cell/tissue extracts
Keratinocytes with EGF 2.4 (ng per I07 cells) n.d.
Keratinocytes without EGF 1.6 n.d.
Human epidermis I (ng per g wet wt) n.d.
Human dermis 4-6 n.d.
Oral SCC (6) 2-6 n.d.
Conditioned media
Keratinocytes with EGF 16 (ng per I07 cells per 24 h) 0.45
Keratinocytes without EGF 8 0.35
aAcidified cell extracts or acid treated CM. bActive TGF-P detected
without acid treatment. n.d. (not done).
All tumours stained, with varying intensity, for the EGFR.
The results for the 14 SCC tested are summarised in Table
III. A regression coefficient analysis of TGF-a levels and the
EGFR stain index showed a highly significant inverse cor-
relation. (The highest levels of TGF-x were seen in tumours
having the lowest EGFR stain index, t = - 3.66, P = 0.003.)
A weaker relationship was also observed between TGF-a
levels and the histological type of the tumour. (Highest levels
of TGF-a were seen in the poorly differentiated tumours;
t= 2.23, P = 0.046.) No correlation was observed between
EGFR expression and the histological type of the tumour.
Production ofpre-pro EGF
Pre-pro EGF transcripts (5.0 kb) were absent from normal
keratinocytes and all oral SCC, though cross-hybridisation was
seen to bands at 4.5, 10 and 2.3 kb (not shown). These tran-
scripts were not detected when the filters were re-hybridised
with a 21-mer homologous to EGF but not TGF-a. It seems
likely that the 4.5 kb transcript represents cross-hybridisation
Table III Relationship between TGF-a and EGFR1 staining intensity in oral squamous
cell carcinomas
EGFRI stain intensity 4 2 2 2 4 4 4 4 6 4 4 4 6 6
Tumour proportion 2 4 5 5 4 4 4 4 3 5 5 5 4 5
EGFR1 stain index 8 8 10 10 16 16 16 16 18 20 20 20 24 30
TGFx detected 9 4.5 5.2 2.0 2.1 2.2 1.2 0.97 0.55 1.1 2.1 1.0 1.1 0.97
(ng g ' wet wt)
Histological type 5 4 3 1 5 5 3 1 3 3 4 2 3 1
Regression analysis: log TGFa detected = 0.898 - 0.0392 EGFR1 stain index (s.e. = 0.01, t = +3.66,
P = 0.003); log TGFa detected = -0.140 + 0.127 histological type (s.e. = 0.06, t, = 2.23, P = 0.046).
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with the TGF-a sequence but the nature of the remaining
transcripts is unclear. The failure to detect transcripts in skin
and keratinocytes confirms earlier results for rat skin (March
& Green, 1986) and human skin (Edler et al., 1989).
Discussion
Production oftransforming growthfactors by cultured
keratinocytes and skin
Normal cultured human keratinocytes express TGF-a trans-
cripts and protein (Figures I and 2). Similar data for keratin-
ocytes has been reported by Coffey et al. (1987). Percoll
density gradient separation of these cells suggests that TGF-o
transcripts predominate in the proliferative, basal cell com-
partment (Figure 2). As keratinocytes are able to respond to
exogenous TGF-a (Barrandon & Green, 1987) and possess
EGF-receptors (Rheinwald & Green, 1977; O'Keefe et al.,
1982), our data are consistent with an autocrine role for
TGF-a in the regulation of in vitro keratinocyte proliferation.
We were unable to identify conclusively TGF- o transcripts
in normal adult skin by Northern blot analysis of 10pg of
poly A + RNA. Although these transcripts have been de-
tected in neonatal skin (Coffey et al., 1987) and adult skin
(Elder et al., 1989) levels are greatly reduced compared with
cultured keratinocytes. Our failure to detect transcripts (Fig-
ure 2) may be due to the low abundance of TGF-a protein in
adult tissue (neonatal foreskin 1.5 ng per g wet wt; adult
skin 0.16-0.35 ng per g wet wt). The finding that EGF
increases the level of TGF-x transcripts and secretion of
TGF-a protein in vitro (Table I; Coffey et al., 1987) may be
of physiological relevance since both growth factors are
found in skin and epidermal extracts (Hoath et al., 1984,
1985; Coffey et al., 1987; this paper) and the target EGF-
receptors are present in human epidermis (Nanney et al.,
1984; Green & Couchman, 1985) and other epithelia (Part-
ridge et al., 1987).
TGF-a protein has been detected by immunocytochemistry
throughout all viable cell layers in neonatal foreskin (Coffey
et al., 1987) and normal adult skin (Gottleib et al., 1988).
Our in vitro data suggest that synthesis of TGF-a may
predominate in basal cells with proliferative potential. How-
ever, as the exact sites of epidermal TGF-a synthesis in vivo
have not been established, the possibility that autocrine prod-
uction of TGF-a influences cell proliferation in normal epi-
dermis remains to be established.
TGF-P1 transcripts were detected in skin (Figure 4) and in
cultured keratinocytes (Figure 3 and 4) with transcripts in
both the basal and differentiating cell compartments. Stimu-
lation of keratinocytes with EGF increased the level of these
transcripts (Figures 3 and 4). TGF-P protein was detected
both in extracts of cultured keratinocytes (2.4 ng per 107
cells) and in adult epidermis (1 ng per g wet wt; Table II).
Analysis of keratinocyte CM suggests that the majority of
TGF-P present (>95%) is in a latent form, perhaps indi-
cating that the physiological regulation of this molecule may
reside in its activation rather than its presence in the cellular
milieux.
Given that exogenous TGF-1 has been shown to inhibit
the growth of cultured keratinocytes (Shipley et al., 1986;
Partridge, unpublished observations) this molecule could po-
tentially play a 'feedback' role in regulating keratinocyte
proliferation in vitro and in vivo (Ozanne et al., 1986; Shipley
et al., 1986; Akhurst et al., 1988).
Production oftransforming growthfi.tors by oral SCC
The detection of TGF-xo transcripts (Figure 1) and EGFR
(Table II) in all oral SCC examined, together with the highly
significant inverse correlation between TGF-a protein and
EGFR levels in the SCC (Table III), strongly suggests that
an autocrine growth factor loop also influences growth cont-
rol in these tumours. Generally higher levels of TGF-x were
detected in SCC (0.55-9 ng per g wet wt) when compared to
normal adult skin (0.16-0.35 mg per g wet wt). The binding
of EGF or TGF-a to the EGFR results in clustering and
internalisation of the receptor and ultimately in degradation
of both receptor and ligand in lysosomes (Schlessinger et al.,
1978). Hence one possible explanation for this inverse cor-
relation could be that tumours are actively metabolising
TGF-a and EGFR. Those tumours with an abundance of
EGFR may degrade TGF-a more efficiently leading to deple-
tion of ligand within the tumour. Alternatively, those tu-
mours with low levels of EGFR may degrade TGF-a less
efficiently leading to accumulation of ligand. The above ex-
planations, although attractive, take no account of other
multiple growth factor interactions which may affect ligand
processing and cell growth and is clearly only one facet of a
complex regulatory growth mechanism.
The correlation between high levels of TGF-a and lack of
tumour differentiation is also interesting. Considered together
with the data from cultured keratinocytes the production of
TGF-a again appears to be predominantly associated with
relatively undifferentiated cell types. Although to date we can
only report the finding of TGF-P in acidified cell extracts of
oral SCC and have no conclusive proof that the active form
of TGF-P is present it is possible that lack of normal neg-
ative regulatory response to TGF-P may contribute to con-
tinued growth of malignant epithelial cells in vivo (Ozanne et
al., 1986; Shipley et al., 1986).
In conclusion, we present evidence of production ofTGF-x
by cultured normal keratinocytes and oral SCC. Although
growth control mechanisms involving this molecule have yet
to be conclusively demonstrated, our evidence is consistent
with an autocrine role for TGF-a in normal and abnormal
cell proliferation, a process that can in principle be modu-
lated by the local production of TGF-P.
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